University of California, Los Angeles (UCLA), Health Sciences

Surgeon General expects COVID-19 vaccine to be available by year’s end

Dr. Jerome Adams addresses UCLA faculty and staff in Grand Rounds lecture

By Sandy Cohen • October 29, 2020

Newswise — Dr. Jerome Adams addresses UCLA faculty and staff in Grand Rounds lecture. 

In a wide-ranging talk with UCLA Health physicians, Wednesday, Oct. 28, United States Surgeon General Jerome Adams, MD, MPH, addressed the politicization of the pandemic and the means of containing the spread of COVID-19. He also offered hope that a vaccine for the virus will be available by year’s end.

Dr. Adams said he has “a high degree of confidence” in a vaccine’s success. “This is the most scrutinized vaccine of all time,” he said. “The vaccine will be safe and effective because of process, not because of politics.”

Meanwhile, he said the “three Ws” — wearing a mask, washing your hands and watching your distance from others — are the most effective ways to curb transmission of the virus and to keep businesses and schools open.

Dr. Adams’ 50-minute talk, delivered via Zoom, was part of the Department of Anesthesiology and Perioperative Medicine’s Grand Rounds series.

The nation’s 20th surgeon general did not shy away from the intersection between public health and politics in his talk just days before the presidential election. He decried how politicization of the pandemic has contributed to confusion and distrust around measures to contain the virus, from mask-wearing to the development of a vaccine.

Even scientists and others dedicated to public health are not impervious to the effects of bias, Dr. Adams said. “Politics, geography, race and biases creep into the way we think about things.”

He said “pre-existing social conditions” played a major role in the effects of COVID-19 on populations of color, noting that members of the Black community have been hospitalized with the virus at five times the rate of white people.

“Social determinants make individuals more susceptible to COVID-19,” he said.

Social justice and racial inequity were themes throughout Dr. Adams’ presentation. Rates of vaccination against influenza are historically lower among people of color, he said, calling the flu “a social justice issue.” He added that more widespread receptivity to the flu vaccine can make acceptance of an eventual COVID-19 vaccine more likely.

“This is the most important flu season of our lives,” he said to the audience of more than 200 health professionals.

Dr. Adams discussed the mental-health costs of the pandemic, noting the increase in suicides and adding that physicians have higher rates of suicide than the general public. He said he will issue a call-to-action regarding suicide awareness in December.

He also said he would issue, in December, a call-to-action about maternal mortality. Black women are three times more likely than white women to die during pregnancy or childbirth, a reality, he said, that is “one of the most glaring examples of bias, racism and inequity” in health care.

“The health of our nation depends on the health of our mothers,” he said.

Already this year, Dr. Adams has released a call-to-action to increase awareness about the risks of hypertension. He said 500,000 people who die this year will have high blood pressure listed as the primary or secondary cause of death. Hypertension also is correlated with a higher risk of complications from COVID-19, he said, adding that one in two adults – himself included – has high blood pressure.

Concluding his talk on a hopeful note, Dr. Adams said he believes distribution of a COVID-19 vaccine will be fair and equitable. To ensure diversity in this effort, the Department of Health and Human Services commissioned the National Academies of Medicine to design a framework for distributing the vaccine in addition to trial parameters.

“I want you to be encouraged, because we’re almost to a vaccine,” he said. “I want you to be encouraged, because we know much more about who is at risk and why, and we’re, therefore, doing a better job of protecting them.

“We know what works to keep people safe,” Dr. Adams said. “When you look at New York, they were the worst in the world for COVID-19, and they were able to drive their transmission rates down to less than 1%. They didn’t have a vaccine; they did it with the three Ws.”




Filters close

Showing results

110 of 4147
Newswise: COVID-19 Peer Hub combats vaccine avoidance amid pandemic
Released: 27-Nov-2020 8:05 AM EST
COVID-19 Peer Hub combats vaccine avoidance amid pandemic
University of South Australia

UniSA researchers are evaluating a new vaccination education initiative – the COVID-19 Peer Hub – to help immunisation and public health professionals to tackle the emerging dangers of vaccine hesitancy amid the pandemic.

Newswise: Long-Term Impacts of COVID-19: Your Mental Health
Released: 25-Nov-2020 2:15 PM EST
Long-Term Impacts of COVID-19: Your Mental Health
Cedars-Sinai

The COVID-19 pandemic has shaped more than half a year of our lives, canceling plans, upending livelihoods and causing feelings of grief, stress and anxiety. And Cedars-Sinai mental health experts say the pandemic could be shaping our mental health well into the future.

Released: 25-Nov-2020 12:45 PM EST
SARS-CoV-2 mutations do not appear to increase transmissibility
University College London

None of the mutations currently documented in the SARS-CoV-2 virus appear to increase its transmissibility in humans, according to a study led by UCL researchers.

Newswise: COVID-19 vaccine candidate tested preclinically at UAB nears first clinical test in people
Released: 25-Nov-2020 11:05 AM EST
COVID-19 vaccine candidate tested preclinically at UAB nears first clinical test in people
University of Alabama at Birmingham

Maryland-based Altimmune Inc., a clinical stage biopharmaceutical company, has submitted an Investigational New Drug, or IND, application to the United States Food and Drug Administration to commence a Phase 1 clinical study of its single-dose intranasal COVID-19 vaccine candidate, AdCOVID.

Released: 25-Nov-2020 11:05 AM EST
BIDMC researchers reveal how genetic variations are linked to COVID-19 disease severity
Beth Israel Lahey Health

New research BIDMC-led sheds light on the genetic risk factors that make individuals more or less susceptible to severe COVID-19.

Newswise: blog-pandemic-scenario-planning-lg-feature2.jpg
Released: 25-Nov-2020 11:05 AM EST
Pandemic Ups Game on Scenario Planning in The Arts
Wallace Foundation

Researcher/Author of new toolkit and report seeks to help arts and culture organizations add scenario planning to their strategic toolbox

Released: 25-Nov-2020 10:30 AM EST
Young people's anxiety levels doubled during first COVID-19 lockdown, says study
University of Bristol

The number of young people with anxiety doubled from 13 per cent to 24 per cent, during the early stages of the COVID-19 pandemic and lockdown 1, according to new research from the University of Bristol.

Newswise: 249837_web.jpg
Released: 25-Nov-2020 10:20 AM EST
Tracking COVID-19 trends in hard-hit states
Louisiana State University

Currently, there are over 10 million confirmed cases and more than 240,000 casualties attributed to COVID-19 in the U.S.

Released: 25-Nov-2020 9:55 AM EST
More Health Systems Join National #MaskUp Campaign
Cleveland Clinic

Many more health systems are joining the national #MaskUp campaign encouraging Americans to stop the spread of COVID-19 by following safety guidelines. Over just a few days, another 19 health systems with hundreds of hospitals united with 100 health systems nationwide with hospitals numbering in the thousands. The public service campaign is critical to the health and well-being of all Americans. It is a plea from healthcare professionals everywhere: wear a mask and follow other precautions to save lives and help get our country back on its feet.

Newswise: delaterre_jpeg.jpg
Released: 25-Nov-2020 7:35 AM EST
Warwick scientists design model to predict cellular drug targets against Covid-19
University of Warwick

The covid-19 virus, like all viruses relies on their host for reproduction


Showing results

110 of 4147

close
0.88968